ActiveGirls: Physical Activity, Hormone Health, and Diabetes Risk in Early Adolescence

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age8+
SponsorMassachusetts General Hospital

About this trial

This study explores how a physical activity program can affect hormone health and diabetes risk in girls ages 8-12 who may be at higher risk. The study aims to address:

* Does the 'ActiveGirls' program meet the needs of girls and families in engaging them to increase physical activity? * What is the trend of markers of diabetes risk and puberty hormones over a 1-year period and how are these levels related to physical activity levels?

Participants in this study will either:

* Participate in a 'full' intensity intervention that includes educational messages (text/email) as well as health coaching visits to support physical activity over a 6 month period * Participate in a delayed 'lower intensity' intervention that includes only educational messages (text/email) * Participants in both groups will complete at-home activity monitoring, two study visits for check-ups and tests, and surveys

Eligibility criteria

Qualifiers

Caregiver: Caregiver of child (ie mother, father, or other legal guardian), English-speaking, Access to a device where they are able to receive study e-mails or texts

Child: English-speaking, Female, ages 8-12 years old at time of enrollment, Pre-menarchal at time of baseline visit, at risk for Polycystic Ovary Syndrome (PCOS)/insulin resistance, as defined by (1) History of maternal PCOS/maternal GDM, (2) BMI >/= 85th percentile, (3) History of premature adrenarche, or (4) Small (<10th %ile) for gestational age

Disqualifiers

Medications at time of enrollment: Metformin, GLP-1R Agonist, Insulin, GnRH agonist

Endocrine conditions that would impact either insulin sensitivity, androgen concentrations, or growth

Insulin dynamics: Type 1 diabetes, Type 2 diabetes, Congenital Hyperinsulinism

Androgen Conditions: Adrenal tumor, Congenital Adrenal Hyperplasia

Trial design

Treatments tested in this trial

  • ActiveGirls Physical Activity Program (Full)
  • ActiveGirls Physical Activity Program (Delayed Lower Intensity)

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Massachusetts General Hospital

Lead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator